Episode 28: The importance of primate models to understand CMV vaccine vectors

Episode 28: The importance of primate models to understand CMV vaccine vectors

We talk with Dr. Daniel Malouli, an assistant professor at the Vaccine and Gene Therapy Institute at the Oregon Health and Science University, OR, who studies how virus-host interactions modulate CMV infection and pathogenesis as well as determine the safety and efficacy of CMV-based vaccine vectors.

Episode 27: IRGM1 regulation of host immunity during vaccination

We talk with Dr. Sumanta Naik, a staff scientist in the Department of Molecular Microbiology at Washington University School of Medicine, who is investigating the role of IRGM1 in type I interferon and B cell responses following vaccination and tuberculosis infection.

Episode 26: Harnessing bacterial components for vaccines and therapeutics

We talk with Dr. Mario Feldman, Professor of Microbiology at Washington University School of Medicine in St. Louis, MO who studies the pathogenesis of Acinetobacter and the biogenesis of bacterial extracellular vesicles.

Episode 25: Understanding the role of T cells to improve vaccination for respiratory pathogens

We talk with Dr. Daniel Hoft, Director of the Division of Infectious Diseases, Allergy & Immunology and the Center for Vaccine Development at Saint Louis University School of Medicine in St. Louis, MO who studies the development of T-cell targeting vaccines against mucosally-invasive intracellular pathogens such as tuberculosis and influenza.

Episode 24: Understanding Tfh cells to improve vaccine-induced antibody responses

We talk with Dr. Michela Locci, Associate Professor of Microbiology at the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA who studies how T follicular helper cells promote optimal germinal cell reactions and antibody responses following vaccination.